Congenital disorders of glycosylation

Inborn Metabolic Diseases: Diagnosis and Treatment

Volumn , Issue , 2012, Pages 607-616

  Jaeken, Jaak ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84956624380     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-15720-2_42     Document Type: Chapter

References (33)

1. Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P et al. (1980) Familial psychomotor retardation with markedly fluctuating serum proteins, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome? Pediatr Res 14:179
2. Jaeken J, Hennet T, Freeze HH, Matthijs G (2008) On the nomenclature of congenital disorders of glycosylation (CDG). J Inherit Metab Dis 31:669-672
3. Jaeken J, Hennet T, Matthijs G, Freeze HH (2009) CDG nomenclature: Time for a change! Biochim Biophys Acta 1792:825-826
4. Jaeken J, Eijk v HG, Heul v d C et al. (1984) Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta 144:245-247
5. Wopereis S, Grunewald S, Morava E et al. (2003) Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis? Clin Chem 49:1839-1845
6. Matthijs G, Schollen E, Schaftingen v E (2004) The prenatal diagnosis of congenital disorders of glycosylation. Prenat Diagn 24:114-116
7. Freeze HH (2006) Genetic defects in the human glycome. Nat Rev Genet 7:537-551
8. Jaeken J, Matthijs G (2007) Congenital disorders of glycosylation: a rapidly expanding disease family. Annu Rev Genomics Hum Genet 8:261-278
9. Coman D, Irving M, Kannu P, Jaeken J, Savarirayan R (2008) The skeletal manifestations of the congenital disorders of glycosylation. Clin Genet 73:507-515
10. Haeuptle MA, Hennet T (2009) Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichollinked oligosaccharides. Hum Mutat 30:1628-1641
11. Morava E, Wosik HN, Sykut-Cegielska J et al. (2009) Ophthalmological abnormalities in children with congenital disorders of glycosylation type I. Br J Ophtalmol 93:350-354
12. Almeida A, Layton M, Karadimitris A (2009) Inherited glycosylphosphatidyl inositol deficiency: a treatable CDG. Biochim Biophys Acta 1792:874-880
13. Bianchi P, Fermo E, Vercellati C et al. (2009) Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene. Hum Mutat 30:1292-1298
14. Denecke J, Kranz C (2009) Hypoglycosylation due to dolichol metabolism defects. Biochim Biophys Acta 1792:888-895
15. Dunwoodie SL (2009) The role of notch in patterning the human vertebral column. Curr Opin Genet Dev 19:329-337
16. Heinonen TY, Maki M (2009) Peters’-plus syndrome is a congenital disorder of glycosylation caused by a defect in the β1,3-glucosyltransferase that modifies thrombospondin type 1 repeats. Ann Med 41:2-10
17. Jaeken J, Vleugels W, Regal L et al. (2009) RFT1-CDG: deafness as a novel feature of congenital disorders of glycosylation. J Inherit Metab Dis 32:756-757
18. Furuichi T, Kayserili H, Hiraoka S et al. (2009) Identification of loss-of-function mutations in SLC35D1 in patients with schneckenbecken dysplasia but not with other severe spondylodysplastic dysplasias group disaeases. J Med Genet 46:562-568
19. Schwartz K, Iolascon A, Verissimo F et al. (2009) Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 41:936-940
20. Sprecher E (2010) Familial tumoral calcinosis: from characterization of a rare phenotype to the pathogenesis of ectopic calcification. J Invest Dermatol 30:652-660
21. Krawitz PM, Schweiger MR, Rodelsperger C et al. (2010) Identity- by-descent filtering of exome sequence data identifies PIGV mutations in hyperphosphatasia mental retardation syndrome. Nat Genet 42:827-829
22. Cantagrel V, Lefeber DJ, Ng BG et al. (2010) SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder. Cell 142:203-217
23. Lubbehusen J, Thiel C, Rind N et al. (2010) Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to new type of congenital disorder of glycosylation. Hum Mol Genet 19:3623-3633 [23b] Mozava E, Lefeber D (2011) CDG an update. J Inherit Metab Dis 34:853-939
24. Grunewald S (2009) The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia). Biochim Biophys Acta 1792:827-834
25. Freeze HH (2009) Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients. Biochim Biophys Acta 1792:835-840
26. De Lonlay P, Seta N (2009) The clinical spectrum of phosphomannose isomerase deficiency, with an evaluation of mannose treatment for CDG-Ib. Biochim Biophys Acta 1792:841-843
27. Al-Owain M, Mohamed S, Kaya N et al. (2009) A novel mutation and first report of dilated cardiomyopathy in ALG6-CDG (CDG-Ic): a case report. Orphanet J Rare Dis 5:7
28. Bovee JV (2008) Multiple osteochondromas. Orphanet J Rare Dis 3:3
29. Hewitt JE (2009) Abnormal glycosylation of dystroglycan in human genetic disease. Biochim Biophys Acta 1792:853-861
30. Simpson MA, Cross H, Proukakis C et al (2004) Infantile onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase. Nat Genet 36:1225-1229
31. Huizing M, Krasnewich DM (2009) Hereditary inclusion body myopathy: A decade of progress. Biochim Biophys Acta 1792:881-887
32. Foulquier F (2009) COG defects, birth and rise! Biochim Biophys Acta 1792:896-902
33. Guillard M, Dimopoulou A, Fischer B et al. (2009) Vacuolar H+- ATPase meets glycosylation in patients with cutis laxa. Biochim Biophys Acta 1792:902-914